Navigation Links
U-M study challenges notion of using Herceptin only for HER2-positive breast cancer
Date:2/26/2013

ANN ARBOR, Mich. New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.

About 20 percent of women with breast cancer have tumors labeled HER2-positive. And since the drug Herceptin has come on the scene, it has had a tremendous impact on survival for these women, particularly when it is given in the adjuvant setting, after surgery to remove the primary cancer. The new findings have potential implications for an additional 65 percent of women with breast cancer.

A recent study based on new analyses of old data found some tumors were incorrectly categorized as HER2-positive and as a result those women received adjuvant Herceptin. It turns out, they benefited as much from the treatment as woman with actual HER2-positive cancer.

"We now provide a molecular explanation for the surprising finding that adjuvant Herceptin benefited some women with HER2-negative breast cancer. If this is confirmed in clinical trials, it could alter our approach to breast cancer treatment," says study author Max S. Wicha, M.D., distinguished professor of oncology and director of the U-M Comprehensive Cancer Center.

At this point, patients with HER2-negative breast cancer are not advised to take Herceptin.

The explanation is that HER2 is selectively expressed in the cancer stem cells of many HER2-negative breast tumors. Because the stem cells represent such a small number of cells in a tumor, the amount of HER2 is not high enough to meet the threshold for a HER2-positive cancer.

The researchers had previously shown HER2 plays an important role in cancer stem cells the small number of cells in a tumor that fuel its growth and spread. These cells represent 1
'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U-M study challenges notion of using Herceptin only for HER2-positive breast cancer
(Date:8/2/2014)... Apervi, the provider of secure ... engineering for big data, announced today that Conflux ... first Enterprise data engineering Platforms to be certified ... founded by the creators of Spark, recently announced ... encourage new development on the distributed, in-memory cluster-computing ...
(Date:8/2/2014)... When the Black Hat conventioneers descend on ... one thing can be always counted on, plenty of FUD ... uncertainty and doubt. The run-up has already made its ... by Reuters on July 31st about how hackers could ... to successfully infect a system with malware, completely undetected, by ...
(Date:8/1/2014)... August 01, 2014 The Judicial Panel ... that testosterone replacement therapy caused strokes, heart attacks, and ... designated Judge Matthew F. Kennelly as the transferee judge ... to the Chicago-based federal court. , As one of ... of appointing committees of attorneys who will move the ...
(Date:8/1/2014)... By Barbara Bronson Gray ... People who are obese and work in manufacturing jobs may have ... suggests. In a study of 32 people -- half were ... obese had endurance times that were about 60 percent longer. ... in task performance. Being older -- 50 to ...
(Date:8/1/2014)... 01, 2014 As it continues to ... women who allegedly experienced the spread of uterine cancers ... surgeries, Bernstein Liebhard LLP notes the growing reaction to ... power morcellators marketed by its Ethicon, Inc. unit from ... York Times, some critics of the company said they ...
Breaking Medicine News(10 mins):Health News:Databricks Certifies Apervi Conflux Director TM on Spark, Supercharging the Data to Insight Journey 2Health News:Databricks Certifies Apervi Conflux Director TM on Spark, Supercharging the Data to Insight Journey 3Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 2Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 3Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 4Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 5Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4
... depends on not just the particular strain of a pathogen, ... its host, according to new research results. Scientists from ... Agriculture,s Agricultural Research Service (USDA ARS) published the results today ... demonstrates that the pattern of gene regulation--how a cell determines ...
... recommendations to ensure that Medicare beneficiaries have access to ... College of Physicians (ACP). The new policy paper, ... released at Internal Medicine 2012, ACP,s annual scientific meeting. ... advantages and disadvantages of proposals to reform Medicare in ...
... News) -- American children are being exposed to background ... finds. For the study, researchers surveyed over ... 8 months to 8 years old. After taking other ... race, age and family income, the researchers also found ...
... By Serena Gordon HealthDay Reporter , FRIDAY, April ... juvenile open-angle glaucoma, A.J. Esguerra said he,s tried not to let ... not the end of the world," said Esguerra, now 23 and ... activities, and I look at it as just one other thing ...
... mysterious, difficult-to-diagnose, and potentially deadly disease that was ... if treatment is started within the first month ... by researchers from the Perelman School of Medicine ... 565 cases of this recently discovered paraneoplastic condition, ...
... of more effective cancer drugs could be a step ... Medical School, of how an inbuilt ,security check, operates ... chromosomes. , Most cells in our bodies contain ... identities. The process of chromosome segregation is monitored by ...
Cached Medicine News:Health News:History is key factor in plant disease virulence 2Health News:History is key factor in plant disease virulence 3Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 2Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 3Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 4Health News:U.S. Children Exposed to Hours of Background TV Daily 2Health News:For Some, Glaucoma Strikes at a Young Age 2Health News:Early treatment improves outcomes in rare, often undiagnosed form of encephalitis 2Health News:Warwick scientists uncover how 'checkpoint' proteins bind chromosomes 2
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
(Date:7/31/2014)... July 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... Amar Singh , Chief Business Officer and Executive Vice President. ... on July 30. "Sorrento is deeply saddened and ... Our immediate thoughts go to Amar,s family and friends," said ... Officer. Mr. Singh joined Sorrento in January ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ... antibodies for the treatment of autoimmune diseases, asthma ... results for the second quarter ended June 30, 2014 ... "In the second quarter, we presented ... International Conference (ATS) demonstrating three novel mechanisms of ...
Breaking Medicine Technology:Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8
... 2011 The ophthalmic therapeutics company Xcovery Vision announced ... and Dr. Ken Mandell, President and COO, will be ... Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale Florida, May ... Serial Entrepreneur recounts his repeated success as founder ...
... KINGSTOWN, R.I., April 25, 2011 On Wednesday, April ... Island Congressman James R. Langevin, Governor Lincoln Chafee, Lieutenant ... laboratory tour and luncheon at its headquarters at 211 ... April 28 Attorney General Peter F. Kilmartin will tour ...
Cached Medicine Technology:Xcovery Vision Founders to Speak at ARVO 2011 2Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials 2
... high resolution diagnostic test for cholesterol components which ... test procedure is simple and can be done ... is clearly flagged. A color coded profile is ... in red and the good HDL in green. ...
... intended as a means of ... assay methods. This ready-to-use, three-level ... significant levels of ammonia and ... for the following instruments: AU ...
... This control is designed for monitoring ... convenient for routine and stat testing and ... Assay values are included for most frequently ... most major chemistry analyzers including: Aeroset, AU ...
... This control is designed to validate visual ... the dipstick into the control the same ... feature is the addition of creatinine and microalbumin. ... results for hCG for early pregnancy detection test ...
Medicine Products: